Literature DB >> 20486786

The interactions between rat-adipose-derived stromal cells, recombinant human bone morphogenetic protein-2, and beta-tricalcium phosphate play an important role in bone tissue engineering.

Ling-Ling E1, Lu-Lu Xu, Xia Wu, Dong-Sheng Wang, Yan Lv, Jia-Zhu Wang, Hong-Chen Liu.   

Abstract

Cells, scaffolds, and growth factors are the three main factors for creating a stem-cell-based tissue-engineered construct, but the interactions between three factors are not very clear. We hereby explored the interactions between rat-adipose-derived stromal cells (rASCs), recombinant human bone morphogenetic protein-2 (rhBMP-2), and beta-tricalcium phosphate (beta-TCP) to provide evidence for their application in bone tissue engineering by evaluating the protein adsorption of beta-TCP, the cell attachment, alkaline phosphatase (ALP) activity/protein, osteocalcin (OCN) content, mineral formation, calcium content, phosphonium content, cell vitality, gene expression, and implantation in the backs of severe combined immunodeficient mice of rhBMP-2 preinducing rASCs seeded onto beta-TCP. The results showed that beta-TCP could adsorb the proteins from the media. The attachment, proliferation, and osteogenic properties of rASCs were supported by beta-TCP, as revealed using scanning electron microscopy. Compared with rASCs cultured on the culture plate, rASCs cultured on beta-TCP had significantly higher ALP activity/protein, OCN content, and mineral formation. These values for rASCs cultured on beta-TCP with rhBMP-2 increased most significantly. The rhBMP-2 significantly increased the calcium content, phosphonium content, and ALP, type I collagen, and OCN mRNA levels of rASCs cultured on beta-TCP. The methylthiazol tetrazolium method revealed that the vitality of rASCs cultured on beta-TCP with or without rhBMP-2 for 4, 7, and 28 days in vitro was insignificantly different. After 8 and 12 weeks of implantation, each group displayed increased bone formation over the 12-week period. The percentage of the new bone formed areas for beta-TCP/rhBMP-2 and beta-TCP was not significantly different. This value for rASCs/beta-TCP construct was significantly higher than that for beta-TCP group, but the maximal and robust bone formation was presented in rASCs/beta-TCP with rhBMP-2. The results implied that stem cells existed in adult rat adipose tissue. beta-TCP could adsorb rhBMP-2 from the media and had osteoinductivity when alone implanted in the back of severe combined immunodeficient mice. beta-TCP was also sufficient to trigger the differentiation of rASCs toward an osteoblastic phenotype without the addition of osteogenic factor. The rhBMP-2 could better sufficiently induce osteogenic differentiation of rASCs seeded onto beta-TCP. The rASCs and rhBMP-2 could promote the dissolution of beta-TCP to provide Ca2+ and PO4(3-) needed for bone formation. The interactions between the three factors could provide an optimizing microenvironment for osteogenic differentiation of rASCs, and this might be essential for sufficient and timely bone formation in vivo. This study may provide insight into the clinical repair of bone defect with ASCs+beta-TCP+rhBMP-2 construct.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20486786     DOI: 10.1089/ten.TEA.2010.0018

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  8 in total

1.  Osteogenic performance of donor-matched human adipose and bone marrow mesenchymal cells under dynamic culture.

Authors:  Wei Wu; Andrew V Le; Julio J Mendez; Julie Chang; Laura E Niklason; Derek M Steinbacher
Journal:  Tissue Eng Part A       Date:  2015-05       Impact factor: 3.845

Review 2.  The roles of bone morphogenetic proteins and their signaling in the osteogenesis of adipose-derived stem cells.

Authors:  Xiao Zhang; Jing Guo; Yongsheng Zhou; Gang Wu
Journal:  Tissue Eng Part B Rev       Date:  2013-08-09       Impact factor: 6.389

3.  The effect of a gelatin β-tricalcium phosphate sponge loaded with mesenchymal stem cells (MSC), bone morphogenic protein-2, and platelet-rich plasma (PRP) on equine articular cartilage defect.

Authors:  Nao Tsuzuki; Jong-pil Seo; Kazutaka Yamada; Shingo Haneda; Hidefumi Furuoka; Yasuhiko Tabata; Naoki Sasaki
Journal:  Can Vet J       Date:  2013-06       Impact factor: 1.008

4.  Short (15 minutes) bone morphogenetic protein-2 treatment stimulates osteogenic differentiation of human adipose stem cells seeded on calcium phosphate scaffolds in vitro.

Authors:  Janice R Overman; Elisabet Farré-Guasch; Marco N Helder; Christiaan M ten Bruggenkate; Engelbert A J M Schulten; Jenneke Klein-Nulend
Journal:  Tissue Eng Part A       Date:  2012-11-16       Impact factor: 3.845

5.  Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells.

Authors:  Fang Su; Shi-Sen Liu; Jun-Li Ma; Dong-Sheng Wang; Ling-Ling E; Hong-Chen Liu
Journal:  Stem Cell Res Ther       Date:  2015-03-12       Impact factor: 6.832

6.  Estrogen enhances the bone regeneration potential of periodontal ligament stem cells derived from osteoporotic rats and seeded on nano-hydroxyapatite/collagen/poly(L-lactide).

Authors:  Ling-Ling E; Wen-Huan Xu; Lin Feng; Yi Liu; Dong-Qing Cai; Ning Wen; Wen-Jie Zheng
Journal:  Int J Mol Med       Date:  2016-04-12       Impact factor: 4.101

7.  Trehalose maintains bioactivity and promotes sustained release of BMP-2 from lyophilized CDHA scaffolds for enhanced osteogenesis in vitro and in vivo.

Authors:  Jun Zhao; Shaoyi Wang; Jianqiang Bao; Xiaojuan Sun; Xiaochen Zhang; Xiuli Zhang; Dongxia Ye; Jie Wei; Changsheng Liu; Xinquan Jiang; Gang Shen; Zhiyuan Zhang
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

8.  Restoration of a Critical Mandibular Bone Defect Using Human Alveolar Bone-Derived Stem Cells and Porous Nano-HA/Collagen/PLA Scaffold.

Authors:  Xing Wang; Helin Xing; Guilan Zhang; Xia Wu; Xuan Zou; Lin Feng; Dongsheng Wang; Meng Li; Jing Zhao; Jianwei Du; Yan Lv; Lingling E; Hongchen Liu
Journal:  Stem Cells Int       Date:  2016-03-28       Impact factor: 5.443

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.